Genetic heterogeneity of granulocytes for the JAK2 V617F mutation in essential thrombocythaemia: implications for mutation detection in peripheral blood-Reference-Cited by-同舟云学术

Genetic heterogeneity of granulocytes for the JAK2 V617F mutation in essential thrombocythaemia: implications for mutation detection in peripheral blood

Published:2006-08 Issue:4 Volume:38 Page:336-342
ISSN:0031-3025
Container-title:Pathology
language:en
Short-container-title:Pathology

Author:

Stevenson William S.,Hoyt Rosemary,Bell Anthony,Guipponi Michel,Juneja Surender,Grigg Andrew P.,Curtis David J.,Scott Hamish S.,Szer Jeff,Alexander Warren S.,Tuckfield Annabel,Roberts Andrew W.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference15 articles.

1. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders;Baxter;Lancet,2005

2. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera;James;Nature,2005

3. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis;Levine;Cancer Cell,2005

4. A gain-of-function mutation of JAK2 in myeloproliferative disorders;Kralovics;N Engl J Med,2005

5. Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment;Murphy;Semin Hematol,1997

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CRISPR/Cas12a-Based Ultrasensitive and Rapid Detection of JAK2 V617F Somatic Mutation in Myeloproliferative Neoplasms;Biosensors;2021-07-24

2. Myeloid somatic mutation panel testing in myeloproliferative neoplasms;Pathology;2021-04

3. The impact of JAK2V617F mutation on different types of thrombosis risk in patients with essential thrombocythemia: a meta-analysis;International Journal of Hematology;2015-05-22

4. Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection ofJAK2V617F and other relevant mutations;British Journal of Haematology;2012-10-11

5. Establishment and characterization of a new human acute myelomonocytic leukemia cell line JIH-3;Leukemia Research;2012-07